Validation of hs-cTnI-Alinity in the early diagnosis of acute myocardial infarction
- Journal
- Clinical chemistry and laboratory medicine (Q1)
- Published
- 27 October 2026
- Study design
- Cohort / observational study
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Paolo Bima, Pedro Lopez-Ayala, Luca Koechlin, Jasper Boeddinghaus, Koray Durak, Arnaud Champetier, et al.
- PMID
- 42936970
- DOI
- 10.1515/cclm-2026-0959
Why clinicians should know about it
- Picked for Emergency Medicine (paper of the day, 28 October 2026): Validates troponin thresholds for rapid ED myocardial infarction pathways
Abstract
OBJECTIVES: It is unknown whether high-sensitivity cardiac troponin I (hs-cTnI) measured on the Alinity platform (hs-cTnI-Alinity), can be used with the same clinical decision values as the Architect platform (hs-cTnI-Architect). METHODS: In an international prospective study, hs-cTnI-Alinity and hs-cTnI-Architect were measured from the same blood samples obtained at 0 h, 1 h, and 2 h from patients presenting to the emergency department with acute chest discomfort. The final diagnosis was centrally adjudicated by two cardiologists. We tested four hypotheses: hs-cTnI-Alinity and hs-cTnI-Architect have (1) excellent analytical agreement, (2) high concordance at common analytical benchmarks (limit-of-detection and upper-reference-limit); (3) high diagnostic accuracy for AMI; and (4) comparable clinical performance for early rule-out and rule-in of AMI. RESULTS: Among 1,573 eligible patients (median age 60 years, 34.7 % women) 7,438 measurements of hs-cTnI-Alinity and hs-cTnI-Architect from the same samples were performed. The prevalence of AMI was 17.7 % (279/1,573). Analytical agreement between hs-cTnI-Alinity and hs-cTnI-Architect was excellent (mean bias -3.6 ng/L [95 % CI -17.3 to 10.1]). Using limit-of-detection and upper-reference-limit as benchmarks, agreement was high. However, major disagreement occurred in 2.5 %, including only one AMI. Diagnostic accuracy for AMI was very high and comparable between hs-cTnI-Alinity and hs-cTnI-Architect (area under the receiver-operating-characteristics curve 0.95 [95 % CI 0.95-0.96] and 0.96 [95 % CI 0.95-0.96]). Sensitivity for ruling-out AMI were >99 % and specificity >93 % and comparable between both assays when applying the ESC 0/1h and ESC 0/2h algorithm derived for hs-cTnI-Architect. CONCLUSIONS: Analytic benchmarks and ESC 0/1h and 0/2h algorithm cut-offs originally derived for hs-cTnI-Architect might be safely applied when using hs-cTnI-Alinity.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.